Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.

J. E. Crowe, B. R. Murphy, R. M. Chanock, R. A. Williamson, C. F. Barbas, D. R. Burton
  • Proceedings of the National Academy of Sciences, February 1994, Proceedings of the National Academy of Sciences
  • DOI: 10.1073/pnas.91.4.1386

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr James E Crowe